Vivani Medical, Inc.

NASDAQ:VANI

Medical - Devices

Healthcare
$1.05 +1.30%

+$0.02 today

Market cap
$94.71M
Beta
3.29
P/E (TTM)
-3.5
EPS (TTM)
-$0.33
52W Low $0.92High $1.92

Volume 0.18M

Average 0.24M

VANI Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Vivani Medical, Inc.NASDAQ: VANI

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin not reported for Q1 FY2026

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
—— QoQ
Last fiscal yearDec 2025
—— YoY
LTMMar 2026
—— YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3 years———
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How VANI compares with its peers on the latest reported figures

VANI Competitors Peer median
Gross Margin for VANI and competitors
Company Period LTM level YoY 3-year change
RCELAVITA Medical, Inc.LTM Mar 202681.4% -4.1 pp-0.3 pp
HYPRHyperfine, Inc.LTM Mar 202651.2% +5.0 pp+36.5 pp
FONRFONAR CorporationLTM Mar 202640.3% -1.0 pp-7.1 pp
ORMPOramed Pharmaceuticals Inc.FY20250.7% —-99.4 pp
MBOTMicrobot Medical Inc.LTM Mar 2026-9.5% ——
IMAImageneBio IncFY2025-29.1% -129.1 pp+282.7 pp
VANIVivani Medical, Inc.FY2025— ——
CRDLCardiol Therapeutics Inc.FY2025— ——
Peer median (excluding VANI) 20.5%-2.5 pp-0.3 pp

Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00357K0424K
Gross Profit00(357K)0(424K)
Gross Margin—————
Research & Development11M14.17M16.97M15.75M18.13M
Selling, General & Admin2.32M5.37M10M8.93M9.43M
Operating Expenses13.32M21.24M26.61M24.68M27.13M
Depreciation & Amortization345K381K357K400K424K
EBITDA(12.43M)(19.16M)(25.3M)(23.09M)(26.19M)
EBITDA Margin—————
Operating Income(13.32M)(21.24M)(26.97M)(24.68M)(27.56M)
Operating Margin—————
Interest Income00000
Interest Expense00000
Other Income / Expenses550K7.35M1.31M1.19M947K
Income Before Tax(12.77M)(13.89M)(25.65M)(23.49M)(26.61M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(12.77M)(13.89M)(25.65M)(23.49M)(26.61M)
Net Margin—————
EPS (Basic)(0.33)(0.17)(0.50)(0.43)(0.43)
EPS (Diluted)(0.33)(0.17)(0.50)(0.43)(0.43)
Weighted Avg Shares36.25M38.24M50.85M54.98M62.39M
Weighted Avg Shares (Diluted)36.25M38.24M50.85M54.98M62.39M

Vivani Medical, Inc.

NASDAQ:VANI

Intrinsic Alpha fair value

Locked

Current Price

$1.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.